Sarcoidosis is an inflammatory multisystemic disease of unknown etiology
characterized by the formation of non-caseating granulomas. Sarcoidosis can
affect any organ, predominantly the lungs, lymphatic system, skin and eyes. While
90% of patients with sarcoidosis have lung involvement, an estimated 5% of
patients with sarcoidosis have clinically manifest cardiac sarcoidosis (CS),
whereas approximately 25% have asymptomatic, clinically silent cardiac
involvement verified by autopsy or imaging studies. CS can present with
conduction disturbances, ventricular arrhythmias, heart failure or sudden cardiac
death. Approximately 30% of
60-year-old patients presenting with unexplained
high degree atrioventricular (AV) block or ventricular tachycardia are diagnosed
with CS, therefore CS should be strongly considered in such patients. CS is the
second leading cause of death among patients affected by sarcoidosis after
pulmonary sarcoidosis, therefore its early recognition is important, because
early treatment may prevent death from cardiovascular involvement. The
establishment of isolated CS diagnosis sometimes can be quite difficult, when
extracardiac disease cannot be verified. The other reason for the difficulty to
diagnose CS is that CS is a chameleon of cardiology and it can mimic (completely
or almost completely) different cardiac diseases, such as arrhythmogenic
cardiomyopathy, giant cell myocarditis, dilated, restrictive and hypertrophic
cardiomyopathies. In this review article we will discuss the current diagnosis
and management of CS and delineate the potential difficulties and pitfalls of
establishing the diagnosis in atypical cases of isolated CS.